Your browser doesn't support javascript.
loading
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program.
Luu, Xuan Quy; Lee, Kyeongmin; Jun, Jae Kwan; Suh, Mina; Jung, Kyu-Won; Choi, Kui Son.
Afiliación
  • Luu XQ; Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Korea.
  • Lee K; Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Korea.
  • Jun JK; National Cancer Control Institute, National Cancer Center, Goyang, 10408, Korea.
  • Suh M; National Cancer Control Institute, National Cancer Center, Goyang, 10408, Korea.
  • Jung KW; National Cancer Control Institute, National Cancer Center, Goyang, 10408, Korea.
  • Choi KS; Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Korea. kschoi@ncc.re.kr.
J Gastroenterol ; 57(7): 464-475, 2022 07.
Article en En | MEDLINE | ID: mdl-35568752
BACKGROUND: Gastric cancer (GC) is the most common cancer type in Korea. Korean National Cancer Screening Program (KNCSP) offer either upper gastrointestinal series (UGIS) or upper endoscopy biennially for adults aged ≥ 40. This study aimed to investigate the effect of cancer screening program on the long-term survival among GC patients. METHODS: A nationwide population-based cohort was constructed based on three national databases. Overall, 46,701 GC patients diagnosed in 2008 and 2009 were included in our final analysis, and they were followed-up until the end of 2019. Survival curves were estimated using the Kaplan-Meier analysis with the log-rank test. Cox proportional-hazards regression analysis was used to report the hazard ratios (HRs) with 95% confidence intervals. RESULTS: A total of 18,614/46,701 (39.9%) patients died during the median follow-up time of 10.5 years. The survival rate was higher among screened patients (65.8%) than never-screened patients (49.1%). Screened patients had 53% (HR, 0.47; 95% CI 0.45-0.48) lower risk of death from GC. The HRs of GC-specific mortality was lower in upper endoscopy group (HR = 0.36; 95% CI = 0.34-0.37) compared with UGIS (HR = 0.69; 95% CI = 0.67-0.73). Screened patients within 2 years prior to cancer diagnosis had a 35% reduction in risk of GC death. The figure decline to approximately 19% among patients with interval time since last screening of > 3 years. CONCLUSIONS: Our findings emphasized the positive effects of GC screening on long-term GC patient survival. Also, patients screened by upper endoscopy or within 2 years before diagnosis had the best survival outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Japón